InnovateIndiana/University Hospitals life sciences startup receives significant funding for developing novel therapeutics for COPD
Each year, more than 25 million people in the U.S. suffer from Chronic Obstructive Pulmonary Disorder (COPD), a life threatening disease that interferes with normal breathing. Although 80 percent of people who die from COPD are former smokers, approximately 3 percent have a genetic disorder (alpha-1 antitrypsin or “AAT deficiency”). To date, there is no […]